Gates Capital Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-732,837
Closed -$28.9M 29
2018
Q3
$28.9M Sell
732,837
-672,427
-48% -$29.4M 0.73% 29
2018
Q2
$62.3M Buy
1,405,264
+195,000
+16% +$9.7M 1.76% 21
2018
Q1
$59M Sell
1,210,264
-284,195
-19% -$14.2M 1.33% 22
2017
Q4
$74.8M Sell
1,494,459
-10,315
-0.7% -$540K 1.8% 18
2017
Q3
$76.2M Sell
1,504,774
-282,671
-16% -$13.3M 2.16% 18
2017
Q2
$67.8M Buy
1,787,445
+685,000
+62% +$27M 2.28% 20
2017
Q1
$42.4M Sell
1,102,445
-924,000
-46% -$27.8M 1.54% 22
2016
Q4
$44.8M Sell
2,026,445
-1,126,741
-36% -$23.1M 1.71% 21
2016
Q3
$50.5M Sell
3,153,186
-740,551
-19% -$8.46M 1.82% 22
2016
Q2
$32.1M Buy
3,893,737
+2,204,851
+131% +$19.6M 1.09% 23
2016
Q1
$11.8M Buy
+1,688,886
New +$8.49M 0.44% 24

Other funds holding CC

Gates Capital Management's CC Position: Q4 2018 in Review

Gates Capital Management sold out of Chemours (CC) in Q4 2018, closing a stake of 732,837 shares — an estimated $28.9M sold.

Gates Capital Management first reported a position in CC in Q1 2016 and held it in 11 quarters. The position peaked at $76.2M in Q3 2017. 506 funds tracked by Wall St. Rank hold CC as of Q4 2018.

  • Gates Capital Management reported no remaining Chemours position as of Q4 2018 after selling out during the quarter.
  • Gates Capital Management sold 732,837 Chemours shares in Q4 2018, an estimated $28.9M.
  • Gates Capital Management first reported a position in Chemours in Q1 2016 and held it in 11 quarters.
  • Gates Capital Management's Chemours position peaked at $76.2M in Q3 2017.
  • 506 funds tracked by Wall St. Rank held Chemours as of Q4 2018.

Based on Gates Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.